Clinical Trial

Syncope-Asystole Latency Time in Tilt Table Test: The SALT-TILT Study

Study acronym: SALT-TILT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 11, 2024 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
Syncope is a common presenting condition. Pacemaker implantation can significantly reduce syncope recurrences in reflex syncope. However, despite careful selection, a substantial proportion of patients treated with pacemakers suffer recurrences of syncope. It is thought that a pronounced vasodepressor component may hinder the efficacy of pacing in patients, preventing adequate cerebral perfusion during the reflex, thus relativizing the anti-bradycardia function of the pacemaker to prevent syncope. It is hypothesised that the time elapsed from the actual loss of consciousness to the asystole recorded on the ECG during Tilt Table Test may be predictive in terms of response to pacemaker therapy, so this parameter becomes the subject of the present study.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-04.
Trial Details
NCT Number NCT06356207
Lead Sponsor Azienda Ospedaliera di Bolzano
Conditions Syncope, Pacemaker, Asystole, Neurally Mediated Syncope
Enrollment 64 participants
Start Date 2024-03-20
Primary Completion 2026-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2024-04-11